TransMedics Group, Inc. (TMDX): A Bull Case Theory

We came across a bullish thesis on TransMedics Group, Inc. on Global Equity Briefing’s Substack by Ray Myers. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.’s share was trading at $118.97 as of July 31st. TMDX’s trailing and forward P/E were 59.75 and 62.11 respectively according to Yahoo Finance.

Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?

A surgeon in a modern operating theatre performing a transplant surgery with medical technology.

TransMedics is revolutionizing the organ transplant...